Nippon Chemiphar Co., Ltd. (TYO:4539)
1,515.00
-13.00 (-0.85%)
Nov 13, 2026, 2:14 PM JST
Nippon Chemiphar Revenue
Nippon Chemiphar had revenue of 7.64B JPY in the quarter ending September 30, 2026, a decrease of -0.52%. This brings the company's total for the last twelve months to 32.98B, up 0.31% year-over-year. In the fiscal year ending March 31, 2026, Nippon Chemiphar had annual revenue of 33.09B with 1.60% growth. That makes Nippon Chemiphar the 17,290th largest company in the world by revenue and 1,873rd in Japan.
Revenue (ttm)
32.98B
Revenue Growth
+0.31%
P/S Ratio
0.17
Revenue / Employee
37.56M
Employees
878
Market Cap
5.49B
Revenue by Segment
- Pharmaceutical Business 31.87B 96.2%
- Others 1.24B 3.8%
Fiscal year ended Mar 31, 2026 See the full Nippon Chemiphar breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 33.09B | 520.00M | 1.60% |
| Mar 31, 2025 | 32.57B | 1.82B | 5.93% |
| Mar 31, 2024 | 30.75B | -811.00M | -2.57% |
| Mar 31, 2023 | 31.56B | -947.00M | -2.91% |
| Mar 31, 2022 | 32.51B | 965.00M | 3.06% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Pharma Foods International | 63.22B |
| Fuso Pharmaceutical Industries,Ltd. | 62.85B |
| Fuji Pharma | 62.39B |
| Daito Pharmaceutical | 49.53B |
| Koa Shoji Holdings | 24.50B |
| Morishita Jintan | 12.84B |
| Mizuho Medy | 10.82B |
| Wakamoto Pharmaceutical | 9.43B |